Supply Chain Issues Less Likely to Yield Drug Shortages in Canada Versus U.S.
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 1, 2024 -- Drug-related reports of supply chain issues are less likely to result in drug shortages in Canada than in the United States, according to a study published online Oct. 31 in the Journal of the American Medical Association.
Mina Tadrous, Pharm.D., Ph.D., from the University of Toronto, and colleagues compared how frequently reports of drug-related supply chain issues in the United States versus Canada were associated with drug shortages in a longitudinal cross-sectional study.
The researchers found that 49.0 and 34.0 percent of the 104 drug-related reports of supply chain issues in both countries were associated with drug shortages in the United States versus Canada (adjusted hazard ratio, 0.53). The lower risk for drug shortages in Canada versus the United States was consistent before and after the COVID-19 pandemic (adjusted hazard ratios, 0.47 and 0.31, respectively). The shortage risk was double for sole-sourced drugs and almost half for Canadian tier 3 medicines (adjusted hazard ratios, 2.58 and 0.56, respectively) after combining reports of supply chain issues in both countries.
"These findings highlight the need for international cooperation between countries to curb the effects of drug shortages and improve resiliency of the supply chain for drugs," the authors write.
One author disclosed ties to Pfizer and Bristol Myers Squibb.
Abstract/Full Text (subscription or payment may be required)
Editor's Note (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.